Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Oct 15, 2009 (Vol. 29, No. 18)

Neuron DB

  • Various search parameters, links to referenced papers
  • Some of the search features bring up error messages

The elation of falling in love, the sting of a sunburn after a day at the beach, the ability to do long division—none of these would be possible without the elegant network of communication between our neurons. Their speech is that of electrical impulses, spoken in myriad dialects of neurotransmitters and their receptors. So how does one study the various neuron types with their conductance nuances and diverse chemical communications? Well, the Neuron Database at the Yale University School of Medicine is a good place to start. Neuron DB is part of the larger brain initiative SenseLab, and its focus is providing a dynamic database covering three neuronal properties: voltage-gated conductances, neurotransmitters, and neurotransmitter receptors. Visitors to the site can search by these three parameters or they can search for specific types of neurons either alphabetically or by brain region. Additionally, there is a comprehensive citation list of the papers used to compile the database.

  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.


GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Pharmacists and Prescription Drug Misuse Programs

Do you agree that pharmacists should make a greater effort to become more involved with prescription drug-monitoring programs?

More »